Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
6
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
alnylam pharmaceuticals
clinical trials
deals
gene therapy
new york blog main
new york top stories
biotech
bluebird bio
boston
harvard pilgrim health care
hemophilia
hereditary transthyretin amyloidosis
national
novartis
patisiran
rna interference
san diego blog main
san diego top stories
spark therapeutics
achromatopsia
acute lymphoblastic leukemia
akcea therapeutics
alexion pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
archive
athenex
beta-thalassemia
bill cassidy
biomarin pharmaceutical
boehringer ingelheim
boulder/denver blog main
What
gene
6
×
drug
fda
therapy
approves
disease
protein
administration
age
alnylam
approval
aren’t
bigger
biggest
bio
called
caught
causing
cells
chemistry
children
cmc
come
consistent
controls
deal
designed
developers
dicerna
drugs
ema
emerging
employ
ensure
europe
eye
follows
food
gave
genetic
Language
unset
Current search:
gene
×
fda
×
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More